Chemical Compound
erythromycin ethylsuccinate
CAS Registry Number
1264-62-6
Primary Record
erythromycin ethylsuccinate
- In stock
- 7,951 g
- Purity
- 99.3 %
- CAS
- 1264-62-6
Compound Identifiers & Properties
- CAS
- 1264-62-6
- PubChem CID
- 443953
- SMILES
- CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O
- Canonical SMILES
- CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C
Names & Synonyms
- erythromycin ethylsuccinate
- Pediamycin
- Erythroped
- EryPed
- Erythromycin ethyl succinate
- Wyamycin E
- anamycin
- arpimycin
- Eritrocina
- Wyamycin
- Monomycin
- Pediazole
- Esinol
- Paediathrocin
- Erythroden
- Primacine
- EES Granules
- Erymin
- E-Mycin E
- Erythroped fte
- Erythrocin ethyl succinate
- Erythroped pi
- Erythroped sf
- Erythroped a
- Mixture Name
- ERY-PED
- 1264-62-6
- Erythroped pi sf
- EES (Antiobiotic)
- Erythroped fte sf
- E-Mycin
- ERYLIQUID
- REFKAS
- PEDIAMYCIN 400
- E-Mycin-E
- Eryped (TN)
- DURAPAEDIAT
- ERYZOLE
- Erythrocin W (TN)
- Erythromycin, ethyl succinate
- Rommix 125
- erythrocinethylsuccinate
- E.E.S
- Spectrum_001046
- RefChem:55126
- C43H75NO16
- Erythromycin, 2'-(ethyl butanedioate)
- Erythromycin 2'-(ethyl succinate)
- Erythromycin-ethyl succinate
- AC1L9FGS
- Eyrthromycin Ethyl Succinate
- Erythromycin Ethysuccinate
- Spectrum2_000983
- Spectrum3_000419
- Spectrum4_000536
- Spectrum5_000668
- E.E.S.
- erythromycin-ethylsuccinate
- erythromycini ethylsuccinas
- GlyTouCan:G11424FT
- MLS001074901
- DTXSID4022993
- Erythromycin 2'-(ethyl butanedioate)
- Erythromycin, mono(ethyl succinate)
- HSDB 3075
- UNII-1014KSJ86F
- Ethylsuccinate, Erythromycin
- DTXCID902993
- Erythromycin ethylsuccinate [JAN]
- 1014KSJ86F
- SCHEMBL18259
- BSPBio_001978
- KBioGR_001171
- KBioSS_001526
- CHEBI:31555
- Ethyl Succinate, Eyrthromycin
- MLS000028651
- MLS001076672
- Succinate, Eyrthromycin Ethyl
- DivK1c_000764
- Erythromycin ethylsuccinate RS
- NSC-756758
- SPECTRUM1500279
- EINECS 215-033-8
- SPBio_001045
- E.E.S 200
- E.E.S 400
- Erythromycin ethylsuccinate CRS
- MFCD00084692
- NSYZCCDSJNWWJL-YXOIYICCSA-N
- cid_443953
- orb1310577
- CHEMBL1200688
- erythromycin,mono(ethylsuccinate)
- BDBM96262
- E.E.S. (TN)
- ERK5-1B15
- HMS502G06
- KBio1_000764
- KBio2_001526
- KBio2_004094
- KBio2_006662
- KBio3_001198
- (-)-ECG
- BRN 0077638
- NINDS_000764
- Sterile erythromycin ethylsuccinate
- Erythromycin, mono(ethyl succinate) (ester)
- GLXC-07736
- HMS1923I21
- HMS2091D03
- Pharmakon1600-01500279
- E.E.S. 200
- E.E.S. 400
- ERITHROMYCIN ETHYL SUCCINATE
- Erythromycin ethylsuccinate [USP:JAN]
- G11424FT
- HY-B0957
- 2'-(Ethyl butanedioate)erythromycin
- Tox21_113497
- BBF-03813
- CCG-40201
- CID443953
- LMPK05000001
- MSK158695
- NSC756758
- s4060
- SMR000058868
- AKOS008145410
- C43-H75-N-O16
- ZINC169356230
- ACN-037187
- CS-4434
- Erithromicina, 2'-(etil butanodioato)
- MSK158695-100A
- NSC 756758
- Erythromycin ethylsuccinate (JP18/USP)
- ERYTHROMYCIN ETHYLSUCCINATE [MI]
- erythromycin,mono(ethylsuccinate)(ester)
- IDI1_000764
- ERYTHROMYCIN (AS ETHYL SUCCINATE)
- NCGC00021382-03
- NCGC00183038-01
- CPD000058868
- ERYTHROMYCIN ETHYLSUCCINATE [HSDB]
- FE170906
- SAM002548941
- Succinic acid, monoethyl ester, monoester with erythromycin
- CAS-1264-62-6
- ERYTHROMYCIN ETHYLSUCCINATE [VANDF]
- Erythromycin mono(ethyl succinate) (ester)
- SBI-0051367.P003
- 41342-53-4
- ERYTHROMYCIN ETHYLSUCCINATE [USP-RS]
- ERYTHROMYCIN ETHYLSUCCINATE [WHO-DD]
- ERYTHROMYCIN ETHYLSUCCINATE [WHO-IP]
- LS-147492
- B1940
- ERYTHROMYCIN ETHYL SUCCINATE [MART.]
- FT-0625701
- 4-18-00-07416 (Beilstein Handbook Reference)
- succinicacid,monoethylester,monoesterwitherythromycin
- 1264-62-6, 114-07-8 [erythromycin]
- C12796
- D01361
- AB00051980_11
- AB00051980_12
- ERYTHROMYCIN ETHYLSUCCINATE [ORANGE BOOK]
- A805556
- ERYTHROMYCIN ETHYLSUCCINATE [EP MONOGRAPH]
- ERYTHROMYCIN ETHYLSUCCINATE [USP MONOGRAPH]
- ERYTHROMYCINI ETHYLSUCCINAS [WHO-IP LATIN]
- SR-05000001617
- 4-O-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] 1-O-ethyl butanedioate
- ERYZOLE COMPONENT ERYTHROMYCIN ETHYLSUCCINATE
- SR-05000001617-1
- BRD-K51677086-001-12-0
- BRD-K51677086-001-13-8
- PEDIAZOLE COMPONENT ERYTHROMYCIN ETHYLSUCCINATE
- Q27114406
- Erythromycin ethylsuccinate for impurity P identification
- Succinic acid monoethyl ester monoester with erythromycin
- Z608353986
- ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
- STERILE ERYTHROMYCIN ETHYLSUCCINATE [USP MONOGRAPH]
- 4-Nitrophenyl2,3,4,6-tetra-O-acetyl-b-D-thiogalactopyranoside
- EES
- Erythromycin ethylsuccinate for impurity P identification CRS
- Erythromycin ethylsuccinate Solution in Acetonitrile, 100ug/mL
- O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate
- (2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate)
- (2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3,4,6-Trideoxy-2-O-(3-ethoxycarbonylpropanoyl)-3-dimethylamino-beta-D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxopentadecan-13-olide
- (2S,3R,4S,6R)-4-(Dimethylamino)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-6-methyltet
- (2S,3R,4S,6R)-4-(dimethylamino)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl succinate
- (2S,3R,4S,6R)-4-(Dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradecan-6-yl]oxy}-6-methyloxan-3-yl ethyl butanedioate
- (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((2- ethyl butanedioate -3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione
- 215-033-8
- 4-O-((2S,3R,4S,6R)-4-(dimethylamino)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl)oxy)-6-methyloxan-3-yl) 1-O-ethyl butanedioate
- Erythromycin A Ethylsuccinate; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-l-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-2-O-(4-ethoxy-4-oxobutanoyl)-ss-d-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione; Erythromycin A 2'-(ethyl succinate); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-l-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-2-O-(4-ethoxy-4-oxobutanoyl)-beta-d-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione;